Vaginal dryness: a review of current understanding and management strategies

References

• Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin Obstet Gynecol. 2015;58(3):476–491. doi: 10.1097/GRF.0000000000000126.
   PubMed Web of Science ®Google Scholar
• Farenhorst CA, de Wolff L, Arends S, et al. Clinical determinants of vaginal dryness in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2021;39 Suppl 133(6):73–79. doi: 10.55563/clinexprheumatol/hzveng.
   PubMed Web of Science ®Google Scholar
• Smith AB, Fawkes N, Khammo N, et al. The humanistic and economic impact of vaginal dryness in premenopausal, perimenopausal, and postmenopausal women. J Womens Health (Larchmt). 2020;29(11):1457–1463. doi: 10.1089/jwh.2019.8001.
   PubMed Web of Science ®Google Scholar
• Benini V, Ruffolo A, Casiraghi A, et al. New innovations for the treatment of vulvovaginal atrophy: an up-to-date review. Medicina (Lithuania). 2022;58(6):770. doi: 10.3390/medicina58060770.
   PubMed Web of Science ®Google Scholar
• Ryu K-J, Park H, Kim YJ, et al. Comparison of various menopausal symptoms and risk factor analysis in Korean women according to stage of menopause. Maturitas. 2020;140(February):41–48. doi: 10.1016/j.maturitas.2020.05.023.
   PubMedGoogle Scholar
• López DML. Management of genitourinary syndrome of menopause in breast cancer survivors: an update. WJCO. 2022;13(2):71–100. doi: 10.5306/wjco.v13.i2.71.
   Web of Science ®Google Scholar
• Marino JM. Genitourinary syndrome of menopause. J Midwifery Womens Health. 2021;66(6):729–739. doi: 10.1111/jmwh.13277.
   PubMed Web of Science ®Google Scholar
• Leiblum SR, Hayes RD, Wanser RA, et al. Vaginal dryness: a comparison of prevalence and interventions in 11 countries. J Sex Med. 2009;6(9):2425–2433. doi: 10.1111/j.1743-6109.2009.01369.x.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Particco M, et al. The REVIVE (Real Women’s Views of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: country-specific comparisons of postmenopausal women’s perceptions, experiences and needs. Maturitas. 2016;91:81–90. doi: 10.1016/j.maturitas.2016.06.010.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric. 2012;15(1):36–44. doi: 10.3109/13697137.2011.647840.
   PubMed Web of Science ®Google Scholar
• Krychman M, Graham S, Bernick B, et al. The women’s EMPOWER survey: women’s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14(3):425–433. doi: 10.1016/j.jsxm.2017.01.011.
   PubMed Web of Science ®Google Scholar
• Richard-Davis G, Singer A, King DD, et al. Understanding attitudes, beliefs, and behaviors surrounding menopause transition: results from three surveys. Patient Relat Outcome Meas. 2022;13(December):273–286. doi: 10.2147/prom.s375144.
   PubMedGoogle Scholar
• De Seta F, Caruso S, Di Lorenzo G, et al. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: a double-blind randomized placebo-controlled study. Maturitas. 2021;147(March):34–40. doi: 10.1016/j.maturitas.2021.03.002.
   PubMedGoogle Scholar
• Sharma S, Adhikari L, Karmacharya I, et al. Menopausal symptoms among postmenopausal women of a selected municipality: a cross-sectional survey. JNMA J Nepal Med Assoc. 2021;59(243):1155–1160. doi: 10.31729/JNMA.7052.
   PubMed Web of Science ®Google Scholar
• Wysocki S, Kingsberg S, Krychman M. Management of vaginal atrophy: implications from the REVIVE survey. Clin Med Insights Reprod Health. 2014;8:23–30. doi: 10.4137/cmrh.s14498.
   PubMedGoogle Scholar
• Domoney C, Short H, Particco M, et al. Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: results from the REVIVE-EU study. Post Reprod Health. 2020;26(2):101–109. doi: 10.1177/2053369120925193.
   PubMedGoogle Scholar
• Potter N, Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric. 2021;24(1):19–24. doi: 10.1080/13697137.2020.1820478.
   PubMed Web of Science ®Google Scholar
• Logan S, Thu WPP, Ho K, et al. Sexual inactivity and sexual dysfunction in midlife Singaporean women: a prospective cross-sectional study of prevalence and risk factors. Maturitas. 2021;152(July):1–9. doi: 10.1016/j.maturitas.2021.07.002.
   PubMedGoogle Scholar
• Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233–238. doi: 10.1016/j.maturitas.2010.08.001.
   PubMed Web of Science ®Google Scholar
• Beshyah SA, Sherif IH, Chentli F, et al. Management of prolactinomas: a survey of physicians from the Middle East and North Africa. Pituitary. 2017;20(2):231–240. doi: 10.1007/s11102-016-0767-5.
   PubMed Web of Science ®Google Scholar
• Yeganeh L, Boyle J, Teede H, et al. Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric. 2017;20(4):348–355. doi: 10.1080/13697137.2017.1304906.
   PubMed Web of Science ®Google Scholar
• Lin L, Feng P, Yu Q. Attitude and knowledge for menopause management among health professionals in mainland China. Climacteric. 2020;23(6):614–621. doi: 10.1080/13697137.2020.1775809.
   PubMed Web of Science ®Google Scholar
• Kling JM, MacLaughlin KL, Schnatz PF, et al. Menopause management knowledge in postgraduate family medicine, internal medicine, and obstetrics and gynecology residents: a cross-sectional survey. Mayo Clin Proc. 2019;94(2):242–253. doi: 10.1016/j.mayocp.2018.08.033.
   PubMed Web of Science ®Google Scholar
• Armeni E, Mili N, Siliogka E, et al. Menopause medical education around the world: the way forward to serve women’s health. Curr Opin Endocr Metab Res. 2022;26(August):100387. doi: 10.1016/j.coemr.2022.100387.
   Google Scholar
• Macpherson BE, Quinton ND. Menopause and healthcare professional education: a scoping review. Maturitas. 2022;166(August):89–95. doi: 10.1016/j.maturitas.2022.08.009.
   PubMedGoogle Scholar
• Nappi RE, Kingsberg S, Maamari R, et al. The CLOSER (Clarifying Vaginal Atrophy’s Impact on Sex and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med. 2013;10(9):2232–2241. doi: 10.1111/jsm.12235.
   PubMed Web of Science ®Google Scholar
• Simon JA, Kokot-Kierepa M, Goldstein J, et al. Vaginal health in the United States: results from the vaginal health: insights, views & attitudes survey. Menopause. 2013;20(10):1043–1048. doi: 10.1097/GME.0b013e318287342d.
   PubMed Web of Science ®Google Scholar
• Wong BWX, Chan YH, Kramer MS, et al. Factors associated with poor sleep quality in midlife Singaporean women: the Integrated Women’s Health program (IWHP). Sleep Med X. 2023;5:100060. doi: 10.1016/j.sleepx.2022.100060.
   PubMedGoogle Scholar
• Waetjen LE, Crawford SL, Chang P-Y, et al. Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study. Menopause. 2018;25(10):1094–1104. doi: 10.1097/GME.0000000000001130.
   PubMed Web of Science ®Google Scholar
• Graham CA, Štulhofer A, Lange T, et al. Prevalence and predictors of sexual difficulties and associated distress among partnered, sexually active older women in Norway, Denmark, Belgium, and Portugal. Arch Sex Behav. 2020;49(8):2951–2961. doi: 10.1007/s10508-020-01742-7.
   PubMed Web of Science ®Google Scholar
• Zou P, Waliwitiya T, Luo Y, et al. Factors influencing healthy menopause among immigrant women: a scoping review. BMC Womens Health. 2021;21(1):189. doi: 10.1186/s12905-021-01327-z.
   PubMed Web of Science ®Google Scholar
• Cortés YI, Marginean V. Key factors in menopause health disparities and inequities: beyond race and ethnicity. Curr Opin Endocr Metab Res. 2022;26:100389. doi: 10.1016/j.coemr.2022.100389.
   Google Scholar
• Hickey M, Hunter MS, Santoro N, et al. Normalising menopause. BMJ. 2022;377:e069369. doi: 10.1136/bmj-2021-069369.
   PubMedGoogle Scholar
• Jaber RM, Khalifeh SF, Bunni F, et al. Patterns and severity of menopausal symptoms among Jordanian women. J Women Aging. 2017;29(5):428–436. doi: 10.1080/08952841.2016.1213110.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wei J, Yang X, et al. Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in Middle-aged and older women in Beijing community: a cross sectional study. BMC Womens Health. 2022;22(1):558. doi: 10.1186/s12905-022-02099-w.
   PubMed Web of Science ®Google Scholar
• Flynn KE, Lin L, Carter J, et al. Correspondence between clinician ratings of vulvovaginal health and patient-reported sexual function after cancer. J Sex Med. 2021;18(10):1768–1774. doi: 10.1016/j.jsxm.2021.07.011.
   PubMed Web of Science ®Google Scholar
• Angelou K, Grigoriadis T, Diakosavvas M, et al. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020;12(4):e7586. doi: 10.7759/cureus.7586.
   PubMed Web of Science ®Google Scholar
• Stabile G, Ricci G, Scalia MS, et al. Induced dryness stress on human vaginal epithelium: the efficacy of a new vaginal gel. Gels. 2021;7(4):157. doi: 10.3390/gels7040157.
   PubMed Web of Science ®Google Scholar
• Liu JH, Bernick B, Mirkin S. Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion. Expert Opin Drug Deliv. 2020;17(11):1573–1581. doi: 10.1080/17425247.2020.1810662.
   PubMed Web of Science ®Google Scholar
• Lázaro-Carrasco de la Fuente J, Cuerva González M, González Rodríguez S, et al. Early effect of 0.005% estriol vaginal gel on symptoms and signs of vulvovaginal atrophy. J Menopausal Med. 2022;28(2):60–69. doi: 10.6118/jmm.21038.
   PubMedGoogle Scholar
• Hariri L, Rehman A. Estradiol. Treasure Island (FL): StatPearls Publishing; 2022. 31747204.
   Google Scholar
• Kirchheiner K, Smet S, Jürgenliemk-Schulz IM, et al. Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes after definitive chemoradiotherapy in patients with locally advanced cervical cancer: results from the EMBRACE-I study. Int J Radiat Oncol Biol Phys. 2022;112(2):400–413. doi: 10.1016/j.ijrobp.2021.08.036.
   PubMed Web of Science ®Google Scholar
• Crean-Tate KK, Faubion SS, Pederson HJ, et al. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. Am J Obstet Gynecol. 2020;222(2):103–113. doi: 10.1016/j.ajog.2019.08.043.
   PubMed Web of Science ®Google Scholar
• Escobar C, Rosenblum N. Vaginal estrogen—what a urologist should know. Urology. 2021;151:37–43. doi: 10.1016/j.urology.2020.05.034.
   PubMed Web of Science ®Google Scholar
• Faubion SS, et al. The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society. Menopause. 2020;27(9):976–992. doi: 10.1097/GME.0000000000001609.
   PubMed Web of Science ®Google Scholar
• Buzzaccarini G, Marin L, Noventa M, et al. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric. 2021;24(6):560–571. doi: 10.1080/13697137.2021.1898580.
   PubMed Web of Science ®Google Scholar
• dos Santos CCM, Uggioni MLR, Colonetti T, et al. Hyaluronic acid in postmenopause vaginal atrophy: a systematic review. J Sex Med. 2021;18(1):156–166. doi: 10.1016/j.jsxm.2020.10.016.
   PubMed Web of Science ®Google Scholar
• de Arriba SG, Grüntkemeier L, Häuser M, et al. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: prospective, randomised study. PloS One. 2022;17(5):e0266633. doi: 10.1371/journal.pone.0266633.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Barattini DF, Casolati E, et al. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: a prospective randomized trial. Eur J Obstet Gynecol Reprod Biol. 2022;270:239–245. doi: 10.1016/j.ejogrb.2022.01.021.
   PubMed Web of Science ®Google Scholar
• Siriyong T, Subhadhirasakul S, Chanwanitsakul S, et al. Therapeutic effects of traditional Thai herbal blood and wind tonic formulations for treatment of menopausal symptoms. Explore (NY). 2021;17(5):469–474. doi: 10.1016/j.explore.2021.06.002.
   PubMedGoogle Scholar
• Karimi FZ, Nazari N, Rakhshandeh H, et al. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2023;285:41–45. doi: 10.1016/j.ejogrb.2023.03.037.
   PubMed Web of Science ®Google Scholar
• Kim HI, Kim MK, Lee I, et al. Efficacy and safety of a standardized soy and hop extract on menopausal symptoms: a 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial. J Altern Complement Med. 2021;27(11):959–967. doi: 10.1089/acm.2021.0027.
   PubMed Web of Science ®Google Scholar
• Yang Y, Park G, Lee KE. The best-worse scaling approach: prioritizing burdensome menopause symptoms among Cambodian women. Women Health. 2022;62(4):325–335. doi: 10.1080/03630242.2022.2068736.
   PubMed Web of Science ®Google Scholar
• Park D, Yoon JE, Choi B, et al. Complex extract of polygonatum sibiricum and nelumbinis semen improves menopause symptoms via regulation of estrogen receptor beta in an ovariectomized rat model. Nutrients. 2023;15(11):2443. doi: 10.3390/nu15112443.
   PubMed Web of Science ®Google Scholar
• Radnia N, Hosseini S, Vafaei S, et al. The effect of conjugated estrogens vaginal cream and a combined vaginal cream of vitamins D and E in the treatment of genitourinary syndrome. J Family Med Prim Care. 2023;12(3):507–516. doi: 10.4103/jfmpc.jfmpc_1364_22.
   PubMedGoogle Scholar
• Mott MN, Goeders NE. Methamphetamine-induced vaginal lubrication in rats. J Sex Med. 2023;20(9):1145–1152. doi: 10.1093/jsxmed/qdad076.
   PubMed Web of Science ®Google Scholar
• Photiou L, Lin MJ, Dubin DP, et al. Review of non-invasive vulvovaginal rejuvenation. J Eur Acad Dermatol Venereol. 2020;34(4):716–726. doi: 10.1111/jdv.16066.
   PubMed Web of Science ®Google Scholar
• Quick AM, Zvinovski F, Hudson C, et al. Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy. Menopause. 2021;28(6):642–649. doi: 10.1097/GME.0000000000001738.
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Pitsouni E, Douskos A, et al. Intravaginal energy-based devices and sexual health of female cancer survivors: a systematic review and meta-analysis. Lasers Med Sci. 2020;35(1):1–11. doi: 10.1007/s10103-019-02855-9.
   PubMed Web of Science ®Google Scholar
• Zipper R, Pryor B. Evaluation of a novel deep tissue transvaginal near-infrared laser and applicator in an ovine model. Lasers Med Sci. 2022;37(1):639–643. doi: 10.1007/s10103-021-03315-z.
   PubMed Web of Science ®Google Scholar
• Filippini M, Porcari I, Ruffolo AF, et al. CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis. J Sex Med. 2022;19(3):452–470. doi: 10.1016/j.jsxm.2021.12.010.
   PubMed Web of Science ®Google Scholar
• Zipper R, Lamvu G. Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here. J Comp Eff Res. 2022;11(11):843–851. doi: 10.2217/cer-2021-0281.
   PubMed Web of Science ®Google Scholar
• Cruz VL, Steiner ML, Pompei LM, et al. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause. 2018;25(1):21–28. doi: 10.1097/GME.0000000000000955.
   PubMed Web of Science ®Google Scholar
• Paraiso MFR, Ferrando CA, Sokol ER, et al. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial. Menopause. 2020;27(1):50–56. doi: 10.1097/GME.0000000000001416.
   PubMed Web of Science ®Google Scholar
• Ruanphoo P, Bunyavejchevin S. Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial. Menopause. 2020;27(8):858–863. doi: 10.1097/GME.0000000000001542.
   PubMed Web of Science ®Google Scholar
• Aguiar LB, Politano CA, Costa-Paiva L, et al. Efficacy of fractional CO2 laser, promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial. Lasers Surg Med. 2020;52(8):713–720. doi: 10.1002/lsm.23220.
   PubMed Web of Science ®Google Scholar
• Eftekhar T, Forooghifar T, Khalili T, et al. The effect of the CO2 fractional laser or premarin vaginal cream on improving sexual function in menopausal women: a randomized controlled trial. J Lasers Med Sci. 2020;11(3):292–298. doi: 10.34172/jlms.2020.49.
   PubMed Web of Science ®Google Scholar
• Takacs P, Sipos AG, Kozma B, et al. The effect of vaginal microablative fractional CO2 laser treatment on vaginal cytology. Lasers Surg Med. 2020;52(8):708–712. doi: 10.1002/lsm.23211.
   PubMed Web of Science ®Google Scholar
• Li FG, Maheux-Lacroix S, Deans R, et al. Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA. 2021;326(14):1381–1389. doi: 10.1001/jama.2021.14892.
   PubMed Web of Science ®Google Scholar
• Zipper R, Pryor B, Lamvu G. Transvaginal photobiomodulation for the treatment of chronic pelvic pain: a pilot study. Womens Health Rep (New Rochelle). 2021;2(1):518–527. doi: 10.1089/whr.2021.0097.
   PubMedGoogle Scholar
• Hickey M, Baber R, Eden J, et al. Safety and effectiveness of a novel home-use therapeutic ultrasound device for the treatment of vaginal dryness in postmenopausal women: a pilot study. Menopause. 2023;30(4):383–392. doi: 10.1097/GME.0000000000002157.
   PubMed Web of Science ®Google Scholar
• Dutra PFSP, Heinke T, Pinho SC, et al. Comparison of topical fractional CO2 laser and vaginal estrogen for the treatment of genitourinary syndrome in postmenopausal women: a randomized controlled trial. Menopause. 2021;28(7):756–763. doi: 10.1097/GME.0000000000001797.
   PubMed Web of Science ®Google Scholar
• Jang YC, Leung CY, Huang HL. Comparison of severity of genitourinary syndrome of menopause symptoms after carbon dioxide laser vs vaginal estrogen therapy: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(9):E2232563. doi: 10.1001/jamanetworkopen.2022.32563.
   PubMed Web of Science ®Google Scholar
• Le C, Murgia RD, Noell C, et al. Female genitourinary treatments in aesthetics. Clin Dermatol. May 2022;40(3):259–264. doi: 10.1016/j.clindermatol.2021.11.009.
   PubMed Web of Science ®Google Scholar